
Relentlessly focused on turning science into life-transforming therapies for #phelanmcdermidsyndrome.
- Tweets479
- Following707
- Followers324
- Likes428

ALT Graphic about a research study for a novel device to study sleep at home in children with profound autism. Includes details that this is involves use of a wearable, at-home EEG device to measure sleep. Eligibility criteria includes individuals who are 12-19 years old with a Phelan-McDermid syndrome diagnosis and struggle with interrupted sleep and no additional neurological disorders. United States.

ALT A graphic announcing a research update. Title reads, Marvel Announces Shank 3 Preliminary data for MB-204 in Mice. The summary below reads, In a Shank 3 mouse model, Marvel Biosciences reports that their investigational oral drug MB-204 demonstrated efficacy in reducing PMS like behavioral abnormalities. Source cited is Bio Space.






